Obinutuzumab,Rituximab
roche,biogen
['obinu', 'pandora']
opening the pandora box of surrogates outcomes in "long term" hem malignancies
gallium (ga101/obinutuzumab) reminded us that pfs is not a surrogate end point in fl.
when will we have the true correlation mrd/pfs/os in mm?
quid of the new dor outcome? 
MD, PhD | Hematology resident |
Genomic & bioinformatic interests ¦
Father & husband ?? 
Classical & contemporary music ?? passionate